Clinical Trial Details
— Status: Withdrawn
Administrative data
NCT number |
NCT05149846 |
Other study ID # |
BaMI |
Secondary ID |
|
Status |
Withdrawn |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 1, 2023 |
Est. completion date |
December 31, 2024 |
Study information
Verified date |
November 2021 |
Source |
Vastra Gotaland Region |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Study objectives:
To test pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120
seconds apart, followed by 10 minutes rest prior to PCI reduces the risk of myocardial
injury.
Study design:
Single-center, open-label, randomized controlled trial
Study population:
Patients with indication for complex PCI. Patients will be randomized prior to PCI to
pre-conditioning by intracoronary balloon inflation in the target vessel proximal to the
target lesion(s) versus no pre-conditioning followed by a 10-minute waiting period prior to
PCI. PCI will then be performed as per standard of care. Cardiac biomarkers will be drawn at
baseline and 6, 24 and 48 hours after PCI. Cardiac magnetic resonance imaging will be
performed at 48 hours and 6 months post PCI.
Description:
The primary objective of this study is to test pre-conditioning by three consecutive 60
seconds balloon inflations, spaced 120 seconds apart followed by 10 minutes rest prior to
percutaneous coronary intervention (PCI) reduces the risk of myocardial injury.
Except for the extended duration of balloon inflations, no study-specific therapy will be
administered to the patients. All patients will receive treatment according to current
guidelines. A follow-up visit will be performed at approximately 6, 24, 48 hours and at 6
months.
The population studied are patients with indication for complex PCI. Patients will be
randomized, after providing written informed consent, prior to PCI to pre-conditioning by
three consecutive intracoronary balloon inflation in the target vessel proximal to the target
lesion(s) versus no pre-conditioning followed by a 10-minute waiting period prior to PCI, PCI
will then be performed as per standard of care. Cardiac biomarkers will be drawn at baseline
and 6 hours, 24 hours and 48 hours after PCI. Cardiac magnetic resonance imaging will be
performed at 48 hours and 6 months post PCI.
Three consecutive balloon occlusions performed for approximate 60 seconds and spaced
approximate 120 seconds apart, followed by a 10-minute waiting period prior to PCI.
Cardiac Magnetic Resonance imaging (CMR) will be used to assess size of myocardial infarction
at 48±6 hours and 6 months±30 days post PCI. CMR examination includes administration of
contrast and one additional blood test (hematocrit, necessary to assess extracellular
volume).
Echocardiography can be used before randomization as per standard of care before PCI.
Echocardiography will be used to assess wall motion score index, left ventricular ejection
fraction at 24 hours and serial examinations can be performed at the discretion of the PI
12-lead Electrocardiogram (ECG) will be used to assess at baseline, during intervention, at
48 hours and serial examinations can be performed at the discretion of the PI.
Apart from the routine laboratory tests, blood samples (troponin-I, troponin-T, creatine
kinase MB fraction [CKMB]) will be collected at baseline, 6±1 hour, 24±6 hours 48±6 hours
after PCI. After collection blood samples will be analyzed at hospitals clinical laboratory
and destructed directly after analyses.